NEW YORK (GenomeWeb News) — Gene Logic today said it plans to sell its preclinical services business, has hired an investment bank to help with this goal, and is already talking with a possible buyer.
The decision is a departure for Gene Logic, which during a restructuring announced in September said the preclinical business will remain with the company.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.